img

Global Mid-Size Pharmaceutical Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Mid-Size Pharmaceutical Market Research Report 2024

According to MRAResearch’s new survey, global Mid-Size Pharmaceutical market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Mid-Size Pharmaceutical market research.
Key companies engaged in the Mid-Size Pharmaceutical industry include DAIICHI SANKYO COMPANY LIMITED, Eisai Co., Ltd., Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc, Sun Pharmaceutical Industries Ltd, Alexion Pharmaceuticals, Inc., Mallinckrodt, Endo Pharmaceuticals Inc. and Les Laboratories Servier, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Mid-Size Pharmaceutical were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Mid-Size Pharmaceutical market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Mid-Size Pharmaceutical market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


DAIICHI SANKYO COMPANY LIMITED
Eisai Co., Ltd.
Bausch Health Companies Inc.
Regeneron Pharmaceuticals, Inc
Sun Pharmaceutical Industries Ltd
Alexion Pharmaceuticals, Inc.
Mallinckrodt
Endo Pharmaceuticals Inc.
Les Laboratories Servier
UCB S.A.
Segment by Type
Prescription
Over-the-Counter (OTC)

Segment by Application


Cardiovascular Diseases
Pain Management
Diabetes
Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Mid-Size Pharmaceutical report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mid-Size Pharmaceutical Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Prescription
1.2.3 Over-the-Counter (OTC)
1.3 Market by Application
1.3.1 Global Mid-Size Pharmaceutical Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Cardiovascular Diseases
1.3.3 Pain Management
1.3.4 Diabetes
1.3.5 Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mid-Size Pharmaceutical Market Perspective (2018-2033)
2.2 Mid-Size Pharmaceutical Growth Trends by Region
2.2.1 Global Mid-Size Pharmaceutical Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Mid-Size Pharmaceutical Historic Market Size by Region (2018-2023)
2.2.3 Mid-Size Pharmaceutical Forecasted Market Size by Region (2024-2033)
2.3 Mid-Size Pharmaceutical Market Dynamics
2.3.1 Mid-Size Pharmaceutical Industry Trends
2.3.2 Mid-Size Pharmaceutical Market Drivers
2.3.3 Mid-Size Pharmaceutical Market Challenges
2.3.4 Mid-Size Pharmaceutical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mid-Size Pharmaceutical Players by Revenue
3.1.1 Global Top Mid-Size Pharmaceutical Players by Revenue (2018-2023)
3.1.2 Global Mid-Size Pharmaceutical Revenue Market Share by Players (2018-2023)
3.2 Global Mid-Size Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mid-Size Pharmaceutical Revenue
3.4 Global Mid-Size Pharmaceutical Market Concentration Ratio
3.4.1 Global Mid-Size Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mid-Size Pharmaceutical Revenue in 2022
3.5 Mid-Size Pharmaceutical Key Players Head office and Area Served
3.6 Key Players Mid-Size Pharmaceutical Product Solution and Service
3.7 Date of Enter into Mid-Size Pharmaceutical Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mid-Size Pharmaceutical Breakdown Data by Type
4.1 Global Mid-Size Pharmaceutical Historic Market Size by Type (2018-2023)
4.2 Global Mid-Size Pharmaceutical Forecasted Market Size by Type (2024-2033)
5 Mid-Size Pharmaceutical Breakdown Data by Application
5.1 Global Mid-Size Pharmaceutical Historic Market Size by Application (2018-2023)
5.2 Global Mid-Size Pharmaceutical Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Mid-Size Pharmaceutical Market Size (2018-2033)
6.2 North America Mid-Size Pharmaceutical Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Mid-Size Pharmaceutical Market Size by Country (2018-2023)
6.4 North America Mid-Size Pharmaceutical Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mid-Size Pharmaceutical Market Size (2018-2033)
7.2 Europe Mid-Size Pharmaceutical Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Mid-Size Pharmaceutical Market Size by Country (2018-2023)
7.4 Europe Mid-Size Pharmaceutical Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mid-Size Pharmaceutical Market Size (2018-2033)
8.2 Asia-Pacific Mid-Size Pharmaceutical Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Mid-Size Pharmaceutical Market Size by Region (2018-2023)
8.4 Asia-Pacific Mid-Size Pharmaceutical Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mid-Size Pharmaceutical Market Size (2018-2033)
9.2 Latin America Mid-Size Pharmaceutical Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Mid-Size Pharmaceutical Market Size by Country (2018-2023)
9.4 Latin America Mid-Size Pharmaceutical Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mid-Size Pharmaceutical Market Size (2018-2033)
10.2 Middle East & Africa Mid-Size Pharmaceutical Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Mid-Size Pharmaceutical Market Size by Country (2018-2023)
10.4 Middle East & Africa Mid-Size Pharmaceutical Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 DAIICHI SANKYO COMPANY LIMITED
11.1.1 DAIICHI SANKYO COMPANY LIMITED Company Detail
11.1.2 DAIICHI SANKYO COMPANY LIMITED Business Overview
11.1.3 DAIICHI SANKYO COMPANY LIMITED Mid-Size Pharmaceutical Introduction
11.1.4 DAIICHI SANKYO COMPANY LIMITED Revenue in Mid-Size Pharmaceutical Business (2018-2023)
11.1.5 DAIICHI SANKYO COMPANY LIMITED Recent Development
11.2 Eisai Co., Ltd.
11.2.1 Eisai Co., Ltd. Company Detail
11.2.2 Eisai Co., Ltd. Business Overview
11.2.3 Eisai Co., Ltd. Mid-Size Pharmaceutical Introduction
11.2.4 Eisai Co., Ltd. Revenue in Mid-Size Pharmaceutical Business (2018-2023)
11.2.5 Eisai Co., Ltd. Recent Development
11.3 Bausch Health Companies Inc.
11.3.1 Bausch Health Companies Inc. Company Detail
11.3.2 Bausch Health Companies Inc. Business Overview
11.3.3 Bausch Health Companies Inc. Mid-Size Pharmaceutical Introduction
11.3.4 Bausch Health Companies Inc. Revenue in Mid-Size Pharmaceutical Business (2018-2023)
11.3.5 Bausch Health Companies Inc. Recent Development
11.4 Regeneron Pharmaceuticals, Inc
11.4.1 Regeneron Pharmaceuticals, Inc Company Detail
11.4.2 Regeneron Pharmaceuticals, Inc Business Overview
11.4.3 Regeneron Pharmaceuticals, Inc Mid-Size Pharmaceutical Introduction
11.4.4 Regeneron Pharmaceuticals, Inc Revenue in Mid-Size Pharmaceutical Business (2018-2023)
11.4.5 Regeneron Pharmaceuticals, Inc Recent Development
11.5 Sun Pharmaceutical Industries Ltd
11.5.1 Sun Pharmaceutical Industries Ltd Company Detail
11.5.2 Sun Pharmaceutical Industries Ltd Business Overview
11.5.3 Sun Pharmaceutical Industries Ltd Mid-Size Pharmaceutical Introduction
11.5.4 Sun Pharmaceutical Industries Ltd Revenue in Mid-Size Pharmaceutical Business (2018-2023)
11.5.5 Sun Pharmaceutical Industries Ltd Recent Development
11.6 Alexion Pharmaceuticals, Inc.
11.6.1 Alexion Pharmaceuticals, Inc. Company Detail
11.6.2 Alexion Pharmaceuticals, Inc. Business Overview
11.6.3 Alexion Pharmaceuticals, Inc. Mid-Size Pharmaceutical Introduction
11.6.4 Alexion Pharmaceuticals, Inc. Revenue in Mid-Size Pharmaceutical Business (2018-2023)
11.6.5 Alexion Pharmaceuticals, Inc. Recent Development
11.7 Mallinckrodt
11.7.1 Mallinckrodt Company Detail
11.7.2 Mallinckrodt Business Overview
11.7.3 Mallinckrodt Mid-Size Pharmaceutical Introduction
11.7.4 Mallinckrodt Revenue in Mid-Size Pharmaceutical Business (2018-2023)
11.7.5 Mallinckrodt Recent Development
11.8 Endo Pharmaceuticals Inc.
11.8.1 Endo Pharmaceuticals Inc. Company Detail
11.8.2 Endo Pharmaceuticals Inc. Business Overview
11.8.3 Endo Pharmaceuticals Inc. Mid-Size Pharmaceutical Introduction
11.8.4 Endo Pharmaceuticals Inc. Revenue in Mid-Size Pharmaceutical Business (2018-2023)
11.8.5 Endo Pharmaceuticals Inc. Recent Development
11.9 Les Laboratories Servier
11.9.1 Les Laboratories Servier Company Detail
11.9.2 Les Laboratories Servier Business Overview
11.9.3 Les Laboratories Servier Mid-Size Pharmaceutical Introduction
11.9.4 Les Laboratories Servier Revenue in Mid-Size Pharmaceutical Business (2018-2023)
11.9.5 Les Laboratories Servier Recent Development
11.10 UCB S.A.
11.10.1 UCB S.A. Company Detail
11.10.2 UCB S.A. Business Overview
11.10.3 UCB S.A. Mid-Size Pharmaceutical Introduction
11.10.4 UCB S.A. Revenue in Mid-Size Pharmaceutical Business (2018-2023)
11.10.5 UCB S.A. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Mid-Size Pharmaceutical Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Prescription
Table 3. Key Players of Over-the-Counter (OTC)
Table 4. Global Mid-Size Pharmaceutical Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Mid-Size Pharmaceutical Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Mid-Size Pharmaceutical Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Mid-Size Pharmaceutical Market Share by Region (2018-2023)
Table 8. Global Mid-Size Pharmaceutical Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Mid-Size Pharmaceutical Market Share by Region (2024-2033)
Table 10. Mid-Size Pharmaceutical Market Trends
Table 11. Mid-Size Pharmaceutical Market Drivers
Table 12. Mid-Size Pharmaceutical Market Challenges
Table 13. Mid-Size Pharmaceutical Market Restraints
Table 14. Global Mid-Size Pharmaceutical Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Mid-Size Pharmaceutical Market Share by Players (2018-2023)
Table 16. Global Top Mid-Size Pharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mid-Size Pharmaceutical as of 2022)
Table 17. Ranking of Global Top Mid-Size Pharmaceutical Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Mid-Size Pharmaceutical Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Mid-Size Pharmaceutical Product Solution and Service
Table 21. Date of Enter into Mid-Size Pharmaceutical Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Mid-Size Pharmaceutical Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Mid-Size Pharmaceutical Revenue Market Share by Type (2018-2023)
Table 25. Global Mid-Size Pharmaceutical Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Mid-Size Pharmaceutical Revenue Market Share by Type (2024-2033)
Table 27. Global Mid-Size Pharmaceutical Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Mid-Size Pharmaceutical Revenue Market Share by Application (2018-2023)
Table 29. Global Mid-Size Pharmaceutical Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Mid-Size Pharmaceutical Revenue Market Share by Application (2024-2033)
Table 31. North America Mid-Size Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Mid-Size Pharmaceutical Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Mid-Size Pharmaceutical Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Mid-Size Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Mid-Size Pharmaceutical Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Mid-Size Pharmaceutical Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Mid-Size Pharmaceutical Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Mid-Size Pharmaceutical Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Mid-Size Pharmaceutical Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Mid-Size Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Mid-Size Pharmaceutical Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Mid-Size Pharmaceutical Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Mid-Size Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Mid-Size Pharmaceutical Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Mid-Size Pharmaceutical Market Size by Country (2024-2033) & (US$ Million)
Table 46. DAIICHI SANKYO COMPANY LIMITED Company Detail
Table 47. DAIICHI SANKYO COMPANY LIMITED Business Overview
Table 48. DAIICHI SANKYO COMPANY LIMITED Mid-Size Pharmaceutical Product
Table 49. DAIICHI SANKYO COMPANY LIMITED Revenue in Mid-Size Pharmaceutical Business (2018-2023) & (US$ Million)
Table 50. DAIICHI SANKYO COMPANY LIMITED Recent Development
Table 51. Eisai Co., Ltd. Company Detail
Table 52. Eisai Co., Ltd. Business Overview
Table 53. Eisai Co., Ltd. Mid-Size Pharmaceutical Product
Table 54. Eisai Co., Ltd. Revenue in Mid-Size Pharmaceutical Business (2018-2023) & (US$ Million)
Table 55. Eisai Co., Ltd. Recent Development
Table 56. Bausch Health Companies Inc. Company Detail
Table 57. Bausch Health Companies Inc. Business Overview
Table 58. Bausch Health Companies Inc. Mid-Size Pharmaceutical Product
Table 59. Bausch Health Companies Inc. Revenue in Mid-Size Pharmaceutical Business (2018-2023) & (US$ Million)
Table 60. Bausch Health Companies Inc. Recent Development
Table 61. Regeneron Pharmaceuticals, Inc Company Detail
Table 62. Regeneron Pharmaceuticals, Inc Business Overview
Table 63. Regeneron Pharmaceuticals, Inc Mid-Size Pharmaceutical Product
Table 64. Regeneron Pharmaceuticals, Inc Revenue in Mid-Size Pharmaceutical Business (2018-2023) & (US$ Million)
Table 65. Regeneron Pharmaceuticals, Inc Recent Development
Table 66. Sun Pharmaceutical Industries Ltd Company Detail
Table 67. Sun Pharmaceutical Industries Ltd Business Overview
Table 68. Sun Pharmaceutical Industries Ltd Mid-Size Pharmaceutical Product
Table 69. Sun Pharmaceutical Industries Ltd Revenue in Mid-Size Pharmaceutical Business (2018-2023) & (US$ Million)
Table 70. Sun Pharmaceutical Industries Ltd Recent Development
Table 71. Alexion Pharmaceuticals, Inc. Company Detail
Table 72. Alexion Pharmaceuticals, Inc. Business Overview
Table 73. Alexion Pharmaceuticals, Inc. Mid-Size Pharmaceutical Product
Table 74. Alexion Pharmaceuticals, Inc. Revenue in Mid-Size Pharmaceutical Business (2018-2023) & (US$ Million)
Table 75. Alexion Pharmaceuticals, Inc. Recent Development
Table 76. Mallinckrodt Company Detail
Table 77. Mallinckrodt Business Overview
Table 78. Mallinckrodt Mid-Size Pharmaceutical Product
Table 79. Mallinckrodt Revenue in Mid-Size Pharmaceutical Business (2018-2023) & (US$ Million)
Table 80. Mallinckrodt Recent Development
Table 81. Endo Pharmaceuticals Inc. Company Detail
Table 82. Endo Pharmaceuticals Inc. Business Overview
Table 83. Endo Pharmaceuticals Inc. Mid-Size Pharmaceutical Product
Table 84. Endo Pharmaceuticals Inc. Revenue in Mid-Size Pharmaceutical Business (2018-2023) & (US$ Million)
Table 85. Endo Pharmaceuticals Inc. Recent Development
Table 86. Les Laboratories Servier Company Detail
Table 87. Les Laboratories Servier Business Overview
Table 88. Les Laboratories Servier Mid-Size Pharmaceutical Product
Table 89. Les Laboratories Servier Revenue in Mid-Size Pharmaceutical Business (2018-2023) & (US$ Million)
Table 90. Les Laboratories Servier Recent Development
Table 91. UCB S.A. Company Detail
Table 92. UCB S.A. Business Overview
Table 93. UCB S.A. Mid-Size Pharmaceutical Product
Table 94. UCB S.A. Revenue in Mid-Size Pharmaceutical Business (2018-2023) & (US$ Million)
Table 95. UCB S.A. Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mid-Size Pharmaceutical Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Mid-Size Pharmaceutical Market Share by Type: 2022 VS 2033
Figure 3. Prescription Features
Figure 4. Over-the-Counter (OTC) Features
Figure 5. Global Mid-Size Pharmaceutical Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Mid-Size Pharmaceutical Market Share by Application: 2022 VS 2033
Figure 7. Cardiovascular Diseases Case Studies
Figure 8. Pain Management Case Studies
Figure 9. Diabetes Case Studies
Figure 10. Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. Mid-Size Pharmaceutical Report Years Considered
Figure 13. Global Mid-Size Pharmaceutical Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Mid-Size Pharmaceutical Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Mid-Size Pharmaceutical Market Share by Region: 2022 VS 2033
Figure 16. Global Mid-Size Pharmaceutical Market Share by Players in 2022
Figure 17. Global Top Mid-Size Pharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mid-Size Pharmaceutical as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Mid-Size Pharmaceutical Revenue in 2022
Figure 19. North America Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Mid-Size Pharmaceutical Market Share by Country (2018-2033)
Figure 21. United States Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Mid-Size Pharmaceutical Market Share by Country (2018-2033)
Figure 25. Germany Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Mid-Size Pharmaceutical Market Share by Region (2018-2033)
Figure 33. China Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Mid-Size Pharmaceutical Market Share by Country (2018-2033)
Figure 41. Mexico Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Mid-Size Pharmaceutical Market Share by Country (2018-2033)
Figure 45. Turkey Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Mid-Size Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. DAIICHI SANKYO COMPANY LIMITED Revenue Growth Rate in Mid-Size Pharmaceutical Business (2018-2023)
Figure 48. Eisai Co., Ltd. Revenue Growth Rate in Mid-Size Pharmaceutical Business (2018-2023)
Figure 49. Bausch Health Companies Inc. Revenue Growth Rate in Mid-Size Pharmaceutical Business (2018-2023)
Figure 50. Regeneron Pharmaceuticals, Inc Revenue Growth Rate in Mid-Size Pharmaceutical Business (2018-2023)
Figure 51. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Mid-Size Pharmaceutical Business (2018-2023)
Figure 52. Alexion Pharmaceuticals, Inc. Revenue Growth Rate in Mid-Size Pharmaceutical Business (2018-2023)
Figure 53. Mallinckrodt Revenue Growth Rate in Mid-Size Pharmaceutical Business (2018-2023)
Figure 54. Endo Pharmaceuticals Inc. Revenue Growth Rate in Mid-Size Pharmaceutical Business (2018-2023)
Figure 55. Les Laboratories Servier Revenue Growth Rate in Mid-Size Pharmaceutical Business (2018-2023)
Figure 56. UCB S.A. Revenue Growth Rate in Mid-Size Pharmaceutical Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed